Followup of Neutrophil-to-Lymphocyte Ratio and Recurrence of Clear Cell Renal Cell Carcinoma
Abstract
Purpose:
An increase in the pretreatment neutrophil-to-lymphocyte ratio is associated with poor prognosis for various cancers, including renal cell carcinoma. However, the clinical implication of a posttreatment change in the neutrophil-to-lymphocyte ratio in patients with cancer remains unclear.
Materials and Methods:
We reviewed the records of 250 patients with nonmetastatic clear cell renal cell carcinoma and analyzed associations among clinicopathological variables, the preoperative and postoperative neutrophil-to-lymphocyte ratio, and recurrence-free survival.
Results:
The 10-year recurrence-free survival rate for patients with a preoperative neutrophil-to-lymphocyte ratio of 2.7 or greater was significantly lower than that for those with a ratio of less than 2.7 (64.4% vs 83.7%, p = 0.0004). When combined with the postoperative ratio, patients with a preoperative ratio of 2.7 or greater could be further divided into 2 groups with a significantly different prognosis. The 10-year recurrence-free survival rate for patients with a preoperative neutrophil-to-lymphocyte ratio of 2.7 or greater and postoperative ratio of less than 2.7 was significantly lower than that for those with a preoperative and postoperative ratio of 2.7 or greater (52.0% vs 83.5%, p = 0.0487). The latter was similar to the 83.7% for patients with a preoperative ratio of less than 2.7. In patients with recurrence the ratio at recurrence was significantly increased compared with the postoperative ratio (mean ± SD 2.82 ± 1.63 vs 2.00 ± 0.90, p = 0.0090). Multivariate analysis showed that tumor size, pathological tumor stage and the neutrophil-to-lymphocyte ratio change (a combination of the preoperative and postoperative ratios) were independent predictors of recurrence. Using these 3 significant variables patients were stratified into low, intermediate and high risk groups, among which the recurrence-free survival rate significantly differed.
Conclusions:
The posttreatment neutrophil-to-lymphocyte ratio change was a significant prognostic factor for recurrence as well as tumor size and pathological tumor stage in patients with clear cell renal cell carcinoma.
References
- 1 : Cancer statistics, 2004. CA Cancer J Clin2004; 54: 8. Google Scholar
- 2 : Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am2003; 30: 843. Google Scholar
- 3 : Cancer-related inflammation. Nature2008; 454: 436. Google Scholar
- 4 : CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation2004; 110: e560. Google Scholar
- 5 : Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology2010; 52: 1836. Google Scholar
- 6 : Acute phase response in animals: a review. Comp Med2009; 59: 517. Google Scholar
- 7 : C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy. J Urol2005; 173: 52. Link, Google Scholar
- 8 : Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg2003; 90: 215. Google Scholar
- 9 : Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat2009; 114: 155. Google Scholar
- 10 : Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma. BJU Int2007; 99: 77. Google Scholar
- 11 : Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy2001; 102: 5. Google Scholar
- 12 : Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol2005; 91: 181. Google Scholar
- 13 : Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol2010; 102: 742. Google Scholar
- 14 : Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother2009; 58: 15. Google Scholar
- 15 : High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res2010; 16: 5805. Google Scholar
- 16 : Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol2010; 184: 873. Link, Google Scholar
- 17 : AJCC Cancer Staging Manual. New York: Springer-Verlag2002. Google Scholar
- 18 : Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol1982; 6: 655. Google Scholar
- 19 : 2004 WHO classification of the renal tumors of the adults. Eur Urol2006; 49: 798. Google Scholar
- 20 : Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer2003; 88: 348. Google Scholar
- 21 : Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology2010; 76: 766. Google Scholar
- 22 : Postoperative serum C-reactive protein levels in non-small cell lung cancer patients. Ann Thorac Cardiovasc Surg2010; 16: 85. Google Scholar
- 23 : Prognostic factors in renal cell carcinoma. World J Urol2010; 28: 319. Google Scholar
- 24 : Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res2003; 9: 802. Google Scholar
- 25 : A preoperative clinical prognostic model for non-metastatic renal cell carcinoma. BJU Int2003; 92: 901. Google Scholar
- 26 : An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol2002; 168: 2395. Link, Google Scholar
- 27 : A postoperative prognostic nomogram for renal cell carcinoma. J Urol2001; 166: 63. Link, Google Scholar
- 28 : Prognostic assessment of nonmetastatic renal cell carcinoma: a clinically based model. Urology2001; 58: 141. Google Scholar
- 29 : Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol2002; 20: 4559. Google Scholar
Department of Urology, Tokyo Medical University, Tokyo, Japan
